Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-03-01 (canadianinsider.com)
Canadian Solar ($CSIQ) Subsidiary Secures 100 MW Solar Deal with Texas Consortium | Canadian Insider
The only place for free North American stock rankings incorporating insider commitment. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Home of the Canadian Insider Club which offers alerts and premium research.
Read more
2024-10-10 (marketbeat.com)
These 3 Stocks Are Screaming Oversold: Seize the Opportunity
Micron, Biogen, and Regeneron are three stocks that appear oversold and could present substantial buying opportunities for investors seeking recovery plays.
Read more
2024-07-05 (pr-inside.com)
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact ...
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact ...
Read more
2024-06-25 (canadianinsider.com)
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Firm
The only place for free North American stock rankings incorporating insider commitment. Get stock quotes, news, fundamentals and easy to read SEC and SEDI insider filings. Home of the Canadian Insider Club which offers alerts and premium research.
Read more
2024-06-14 (wrbl.com)
BFA Law Notice: Biogen Inc. (Nasdaq: BIIB) Investors that Lost Money on Investment Have the Opportunity to Lead Securities Fraud Lawsuit and are Urged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / June 13, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting https:
Read more
2023-05-16 (finanznachrichten.de)
Biogen share price down today
In US securities trading, Biogen's shares are trading lighter at the moment. The security is currently trading at $308.21. The Biogen share has today on the US stock exchange
Read more
2023-04-04 (masslawyersweekly.com)
Securities - Fraud - Knowingly
Where a securities fraud complaint has been filed over the failed commercial rollout of an innovative treatment for Alzheimer's disease, the complaint must be dismissed because (1) none of the defendants' 25 allegedly false and misleading statements are actionable under the Private Securities
Read more
2022-03-04 (prnewswire.com)
Biogen Inc. Company News: Berger Montague Investigates Securities Fraud Allegations Against Biogen, Inc. (NASDAQ: BIIB); Lead Plaintiff Deadline is April 8, 2022
/PRNewswire/ -- Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities of Biogen, Inc. ("Biogen" or...
Read more
(biospace.com)
SEC Aims Insider Trading Charges at Former Sangamo Therapeutics Executive -
The U.S. Securities and Exchange Commission has leveled charges at a former Sangamo Therapeutics Inc. executive and others for an insider-trading scheme that netted more than $1.5 million in “illegal profits.”
Read more
(statnews.com)
Profiting from ‘legal’ insider trading isn’t always easy
This week in biotechnology: Adam Feuerstein's subscriber-only newsletter digs into PIPEs, Benitec, Vera, Biohaven, and Biogen.
Read more
(ariva.de)
Hardly any impetus for the Biogen share
Biogen's share certificate is currently unremarkable in US securities trading. The stock is currently trading at $284.40.
Read more